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Abstract: In this review article, we discuss the current state of computational modelling of
the nuclear factor-kappa B (NF-κB) signalling pathway. NF-κB is a transcription factor,
which is ubiquitous within cells and controls a number of immune responses, including
inflammation and apoptosis. The NF-κB signalling pathway is tightly regulated,
commencing with activation at the cell membrane, signal transduction through various
components within the cytoplasm, translocation of NF-κB into the nucleus and, finally, the
transcription of various genes relating to the innate and adaptive immune responses. There
have been a number of computational (mathematical) models developed of the signalling
pathway over the past decade. This review describes how these approaches have helped
advance our understanding of NF-κB control.
Keywords: NF-κB; computational biology; agent-based modelling; mathematical
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1. Introduction
Cells use complex networks of interacting molecular components to transfer and process
information. It is increasingly appreciated that the robustness of various cellular processes is rooted in
the dynamic interactions among the cell’s many constituents [1], such as proteins, DNA, RNA and
small molecules. Barkai and Leibler [2] advise that the “computational devices of living cells” are
responsible for many important cellular processes, including metabolic pathways, signalling pathways
and regulatory mechanisms.
Intracellular pathways possess a high degree of complexity, with the role of their constituent
components not only being defined by their individual function, but also by their interaction with other
components [3]. It has recently emerged that many biological components are shared by several
pathways, which merge into large and complex interconnected networks when viewed from a systems
perspective. Oltvai and Barabasi [4] propose that we build on this approach and believe that by viewing
a cell as an interconnected network of genes and proteins, we will be able to develop viable strategies
for addressing the complexity of living systems. The field of systems biology is concerned with
understanding this complexity by focusing on the interactions between the various components of living
cells [5]. It has more recently become associated with the use of an integrative approach, combining
experimental and computational modelling to identify the molecular mechanisms underlying the
properties and behaviours of complex biological systems, termed computational biology [6,7].
The discipline of computational biology encompasses all fields of biology that have joined forces with
computer science and engineering. Just as biology can be broken down into sub-disciplines, such as cell
biology, biochemistry, immunology, etc., a growing specialty within the discipline of computational
biology relates to the immune system and has been termed computational immunology. The immune
system provides our primary protection mechanism against invading organisms (e.g., bacteria, viruses,
fungi or other microorganisms) and cells that have become uncontrollably changed [8]. Many of the
responses following the identification of a foreign organism or toxic molecule are destructive in nature
and facilitate the containment or removal of the pathogen [9]. Following recognition of a pathogen,
a plethora of immune responses develop over time, which are caused by modification to the activity
of intracellular enzymes or activation factors, e.g., transcription factors, regulating expression of genes
involved in host defence. There are a number of well-defined signalling pathways in humans that lead to
activation of gene expression. Of these, the nuclear factor-kappa B (NF-κB) pathway is believed to be
central to the regulation of inflammatory responses, as scientists have not yet discovered an inflammatory
gene that is not controlled, at least in part, by NF-κB.
The aim of the present review is to discuss the development of computational modelling of the
NF-κB signalling pathway and how this has facilitated significant advancements in our understanding
of its regulation.
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2. The NF-κB Signalling Pathway
The transcription factor NF-κB is central to the regulation of response to infections (through the
innate and adaptive immune responses) [10,11]. NF-κB is a collective name for a family of inducible
dimeric transcription factors and, as such, is an essential intracellular messenger, which in conjunction
with its signalling pathway, connects various extracellular stimuli to the induction of gene expression.
NF-κB gains its name following its discovery by Sen and Baltimore [12] as an enhancer (regulator of
DNA transcription) of the κ light chain (a sequence of amino acids) in B-cells (a type of white blood
cell that makes antibodies). NF-κB plays a critical role in inflammation, immunity, cell proliferation,
cell differentiation and cell survival [13]. It is central to the control of immune and inflammatory genes
that are activated in response to infection [10,11]. In addition, NF-κB controls programmed cell death
through regulation of anti-apoptotic signals [14]. It is activated by a large number of diverse extracellular
stimuli, including cytokines [15], reactive oxygen species [16,17], viral infection [18], bacterial cell
wall products [19], DNA damage [20], shear stress [21] and shape changes [22]. Although NF-κB
is ubiquitously expressed, its action is regulated in a well-controlled, cell-type and stimulus-specific
manner, which provides for a multitude of roles and effects [23].
In keeping with the large number of extracellular signals that activate the NF-κB signalling pathway,
the transcription factor also regulates a large list of target genes [11]. Due to the wide ranging gene
products that are regulated through NF-κB and its associated signalling pathway, NF-κB has been
deemed a “Master” regulator of inflammation [23]. Figure 1 provides a diagrammatic representation of
NF-κB activation. Dysregulation of inflammatory responses controlled by the pathway underlies many
of the most common and devastating diseases, such as atherosclerosis and arthritis. In addition, NF-κB
is central to the progression of certain types of cancers ([24] and the special issue of Cell Research,
vol 21, 2010).
NF-κB transcription factors are hetero- or homo-dimers, containing members of the Rel family of
proteins. This family is composed of five distinct gene products, which are related by a conserved
region known as the Rel homology domain (RHD), which is responsible for nuclear localisation,
DNA-binding (to κB sites) and dimerisation [25]. The NF-κB family is divided into two functionally
distinct subfamilies: the first is encoded by large precursor proteins that are subsequently processed into
smaller subunits with strong DNA-binding activity and weak transcriptional activation potential
(p105/NF-κB1 and p100/NF-κB2); the second is translated as mature proteins that bind to DNA weakly
and contain potent transcriptional activation domains (RelA, RelB and c-Rel [26,27]. A key regulator of
the pathway is the inhibitor of NF-κB (IκB), which retains NF-κB in the cytoplasm of resting cells. IκB
is a member of a larger family of molecules that include IκBα, IκBβ, IκB￿ and IκBγ. The best
characterised IκB is IκBα, mainly because it was the first member of the family to be cloned [25].
NF-κB activation is controlled by two distinct pathways, which have been termed the canonical and
non-canonical pathways [28–30] (see Figure 2 for a diagram of the two NF-κB signalling pathways).
Activation of the canonical pathway leads to IKK (IκB kinase)-mediated phosphorylation,
ubiquitination and degradation of IκB, allowing the transcription factor to translocate to the nucleus and
activate genes bearing cognate binding sites. The non-canonical pathway is IκBα-degradation
independent and involves activation of NIK and regulation of the p100 NF-κB subunit. Activation of
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NF-κB results in the induction of gene expression of a number of inflammatory response proteins,
including the inhibitor IκBα, thus providing a negative feedback mechanism that controls transient
activation of the pathway.
Figure 1. High-level representation of how the multitude of inducers of the NF-κB signalling
pathway, which converge on the NF-κB signalling module (NF-κB, IκBα and IKK), before
diverging to regulate a multitude of gene products, has the topology of a bow-tie motif from
systems biology. Pahl [11] advises that there are over 150 known inducers of NF-κB
activation, which can be allocated to a number of categories of environmental stimuli.
Similarly, Pahl advises that more than 150 genes are known to be regulated by NF-κB,
which can again be categorised into a number of key physiological responses.
In addition to the various NF-κB dimers, IκB inhibitor proteins and IKK complexes, there are also
a large number of upstream components that facilitate signal transduction through the pathway.
Of these, the proteins within the cell receptor complex are the pivotal components in facilitating the
cells response to its environment. Most surface receptors are transmembrane in nature and contain an
extracellular, ligand-binding domain, responsible for sensing the incoming signal, and an intracellular
domain, responsible for initiating the propagation of the signal through the cascade of different kinases
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until it reaches the IKK-NF-κB-IκB signalling module. Along with the cell membrane receptor
proteins, the cell receptor complex may also contain co-receptors and adaptor proteins. For example,
following ligation with lipopolysaccharide (LPS), the Toll-like receptor 4 (TLR4) protein dimerises and
associates with CD14 (a co-receptor for LPS) and an additional cellular protein MD2 [31] in order to
signal the presence of the bacterial product. Furthermore, some proteins within a receptor complex
mediate the signal transduction between proteins by bringing them together and are referred to as
adaptor proteins. They function as docking proteins to co-locate signalling molecules into multiprotein
signalling complexes. The formation of the receptor-co-receptor-adaptor protein complex and related
events at the level of the receptor have a primary role in signal transduction.
Figure 2. Simplified diagram depicting the two NF-κB signalling pathways. Both the
canonical and non-canonical pathways are initiated through extracellular stimuli. Following
activation of the IKK complex, signal transduction leads to the degradation of IκB and the
resultant release and translocation of the relevant NF-κB heterodimer into the nucleus for
transcriptional activation.
Along with the core components of the signalling network discussed above, another set of
components involved in regulating gene expression are a group of proteins termed modulators.
Modulators are used within signal transduction networks to modify the activity of transcription factors
and often act by binding to them directly and, thus, affect the expression of target genes [32]. With
particular reference to the NF-κB signalling pathway, Li et al. [33] have recently used computational
modelling and analysis of gene expression profiles to predict a number of key modulators and the
associated target genes of NF-κB. They identified 365 candidate modulators of the RelA monomer,
including 334 that had not been previously reported. They developed a probabilistic model of the
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regulatory network and discovered a number of functional subnetworks, which were believed to contain
new pathways for modulating RelA transcriptional activity and specificity.
Figure 3. Unified Modelling Language (UML) class association diagram for the canonical
NF-κB signalling pathway. The layout used follows the spatial aspects of the cascade of
component relationships involved in the biological system from cell membrane activation
down to gene transcription within the nucleus. The diagram conveys directed relationships
by the labels at each end of the connectors. The arrowheads pointing towards the
nuclear receptor convey inheritance, such that exporting receptor and importing receptor
are sub-types. The unfilled diamonds on the NF-κB-IκB complex denote aggregation, i.e.,
an IκB component and an NF-κB component aggregate to form the inhibited complex.
3. Existing Computational Models of NF-κB
A significant body of knowledge has been generated through wet-lab experimentation since the
discovery of NF-κB in 1986. Following the move by a large section of the scientific community away
from the reductionist approaches and towards a systems-level understanding, the use of computational
modelling and simulation has been adopted by a growing number of research groups investigating
NF-κB. Because of the central role of the NF-κB inhibitor in the control of transcriptional activation, its
regulation has been the focus of the majority of in silico models of pathway regulation. Recently,
equation-based and agent-based models have been used within a predictive capacity to generate
Computation 2014, 2 137
hypotheses for testing through additional wet-lab experimentation. We will review existing
computational models that have provided the major advancements throughout this section. Figure 3
depicts a UML (Unified Modelling Language) class association diagram for the canonical signalling
pathway, which has formed the basis for the majority of the computational models to date.
3.1. Deterministic Differential Equation Models
The first mathematical model of NF-κB dynamics was developed by Carlotti et al. [34]. This model
used reaction kinetics, built with Microsoft Excel and Visual Basic, to focus on IκBα association and
dissociation rates, along with IκBα and NF-κB translocation between the cytoplasm and the nucleus.
The first model of the wider NF-κB signalling pathway, however, was that of Hoffmann et al. [35].
Hoffmann et al. developed an ODE-based computational model using Gepasi software (version 3.1;
Mendes [36,37]). They were particularly interested in the temporal control of NF-κB activation by the
coordinated degradation and synthesis of IκB proteins. The model therefore focuses on reactions that
govern IκB dynamics, including synthesis and degradation, along with cellular localisation
and association/dissociation with NF-κB.
The Hoffmann model comprised a system of 24 ODEs describing reaction kinetics equations of the
change in concentration (with respect to time) of cytoplasmic and nuclear NF-κB, cytoplasmic and
nuclear IκB (-α, -β and -￿), cytoplasmic IKK and resultant complexes that they may form. The model
also contained 30 parameters, which were gained using a combination of biochemical experimentation
within their lab, a review of published literature and estimation through model fitting techniques.
The model describes the differential functions of IκBα, β and ￿ isoforms on the regulation of NF-κB
activation and used knockout mice for the three isoforms, cross-bred to yield double-knockout cells
where NF-κB was inhibited by a single IκB isoform. These cells were stimulated with TNFα in order
to induce the NF-κB signalling response. Their conclusions from wet-lab experimentation were that
coordinated degradation, synthesis and localisation of all three IκB isoforms is required to generate the
characteristic NF-κB activation profile.
Three computational models were developed to represent these double knockouts: β-/-￿-/- (IκBα),
α-/-￿-/- (IκBβ) and α-/-β-/- (IκB￿), which were calibrated so that simulation results were consistent with
wet-lab dynamics. Simulation yielded two very different results, predicting that: (i) IκBαmediates rapid
NF-κB activation and strong negative feedback regulation, resulting in an oscillatory NF-κB activation
profile; and (ii) IκBβ and IκB￿ respond more slowly to IKK activation and act to dampen the long-term
oscillations of the NF-κB response.
The authors subsequently built on this initial work by performing new wet-lab knockout experiments
to isolate cleanly the endogenous free- and bound-IκB protein pools and probed their degradation with
kinase knockouts and pharmacological inhibitors [38]. They used the previous model to investigate the
steady-state regulation of the NF-κB signalling module and its impact on stimulus responsiveness,
through manipulating rate constants of IκB isoform degradation through either IKK-mediated or
IKK-independent processes. This in silico experimentation revealed a homeostatic NF-κB signalling
module in which differential degradation rates of free and bound pools of IκB represent a novel
cross-regulation mechanism that imparts functional robustness to the signalling module.
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Recently, Cheong et al. [39] have reviewed this initial work and argue that the functions of the three
IκB isoforms combine to allow the signalling module to distinguish between short and long lasting
stimuli. Furthermore, Kearns et al. [40] through reimplementation in MATLAB and augmentation of
the model, discovered that IκB￿ provides negative feedback to control NF-κB oscillatory dynamics, but
that a delay in IκB￿ transcription renders this negative feedback in antiphase to that of IκBα. The
authors therefore suggest that IκB￿ has a role in dampening the IκBα-mediated oscillations during
long-lasting NF-κB activity. This must be tempered, however, as subsequent work by Paszek et al. [41]
(see the semi-stochastic modelling section) suggested that the antiphase negative feedback by IκBα and
IκB￿ is optimised to generate heterogeneous NF-κB oscillations between cells and, thus,
a population-level robustness to external perturbations.
Following additional wet-lab experimentation, they also hypothesise that the relative strength of
IκBα and IκB￿ feedback mechanisms and their temporal relationships to each other may account for
cell type-specific regulation of NF-κB dynamics. Basak et al. [42] have also updated the model to
introduce the p100 protein, which is part of the non-canonical signalling pathway, and LPS induction of
IKK-mediated IκB degradation. They showed that p100 acts as an inhibitor of NF-κB activation and
termed this IκBδ, as it was found to be a bona fide IκB protein. They used the model to explore
feedback regulation and dynamics of p100 and suggest that there may be crosstalk between the
canonical and non-canonical signalling pathways. More recently, Shih et al. [43] have further
augmented the model of Basak et al. and found that the newly discovered inhibitor IκBδ provides
negative feedback in the presence of persistent, pathogen-triggered signals, by dampening NF-κB
responses during sequential stimulation events. The authors subsequently updated this model to make it
specific to dendritic cells (DC) and discovered that RelB is regulated by classical IκBs (IκBα and IκB￿)
during DC activation and, therefore, integrates the canonical and non-canonical pathways [44]. This
computational model is the first to model the kinetics of both RelA and RelB containing dimers.
Despite the successes of these models from the Hoffmann group, it has been argued that they appear
to have a number of limitations. The models were calibrated against population-based wet-lab
experimentation that used the average of multiple cells rather than single-cell analysis. As such, they
did not reflect the large variation in behaviours between individual cells that is inherent to the NF-κB
signalling pathway. With this in mind, the work by Nelson et al. [45] built on the early
population-based model from the Hoffmann group to incorporate functionality for single-cell dynamics,
as seen in their wet-lab results. They used fluorescence imaging of RelA and IκBα to study oscillations
in RelA nucleus-cytoplasm localisation in HeLa cells (human cervical carcinoma cells, named after
Henrietta Lacks, from whom the cell line was derived [46]) and SK-N-AS cells (human s-type
neuroblastoma cells that possess deregulated NF-κB signalling). Their work showed that single-cell
time-lapse imaging and computational modelling of RelA localisation showed asynchronous
oscillations following cell stimulation that decreased in frequency with increased IκBα transcription.
The authors used the ODE-based model developed by Hoffmann et al. and validated against their own
single-cell experimental data. Their results demonstrated nuclear-cytoplasmic oscillations of NF-κB
during activation and showed that the dynamics of NF-κB translocation are dependent on IκBα
transcription, in agreement with work by Carlotti et al. [34], who showed that regulation of NF-κB
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subcellular localisation is dependent, in part, on the nuclear export function and in part on the
cytoplasmic retention function of IκBα.
Lipniacki et al. [47] used the Hoffmann model as a baseline and amended it in three main ways.
Firstly, the kinetics of the nuclear and cytoplasmic compartments were refined to take into account
differences between their volumes. Secondly, they made use of additional information (i.e.,
assumptions and considerations from publications by external groups) regarding IκBα interactions
within the system; Carlotti et al. [48] and Rice and Ernst [49] suggest that only 10%–15% of the total
NF-κB is not complexed to IκBα in a resting cell (the work by Pogson et al. [50] suggesting that 66%
of IκBα binds to the cytoskeleton had not taken place yet). Thirdly, they re-estimated the mRNA
transcription and translation coefficients through the use of published molecular level data.
Lipniacki et al. utilised a high degree of abstraction and again focused on the NF-κB-IκB signalling
module by using 15 ODEs to model the kinetics of IKK, NF-κB, IκBα and the IKK inhibitor A20 within
the nuclear and cytoplasmic compartments of cells. They removed IκBβ and IκB￿ and approximated the
collective action of all IκB isoforms by IκBα, which is the most active and abundant isoform and also
the only isoform that is lethal if knocked out. They also included three new assumptions around the
dynamics of the IKK complex: (i) resting cells have a neutral form IKKn; (ii) stimulated cells have an
active form IKKa, which phosphorylates IκBα; and (iii) inhibition of IKK was incorporated into the
model, with A20 converting IKKa into the inactive form IKKi, as shown by Krikos et al. [51].
Lipniacki et al., through reference to Yang et al. [52], modified the NF-κB nuclear transport
coefficient (from the Hoffmann model) to incorporate a longer time between the IKK-mediated
phosphorylation of IκBα within the NF-κB-IκBα complex and the translocation of free NF-κB from
the cytoplasm into the nucleus. This modification enabled the model to also take into account the time
needed for ubiquitination and proteolysis, within a single coefficient. Additional assumptions were built
into this revised model around the IKK complex and concerned: the different binding states of the
molecule; the constant synthesis to replace degraded IKK molecules; and the inhibition of IKK by A20,
which was also synthesised as part of the model. Their model therefore incorporates two negative
feedback loops for NF-κB activation, one involving inhibition of free NF-κB via the binding of IκBα
and the other involving the inhibition of IKK by A20. These amendments were made to the existing
code (from Hoffmann et al. [35]), and additional scripts to analyse the resulting simulation data were
developed in MATLAB. The model was validated against published data of Lee et al. [53] regarding
A20-mediated dynamics and the model dynamics of the original Hoffmann model. After parameter
fitting, the authors believed that the model successfully reproduced the time behaviour of wild-type and
A20-deficient cells.
Following the publication of this augmented computational model, the Hoffmann group
(Cheong et al. [54]) reimplemented their model using Cellerator [55], updated their parameter values to
take account of the revisions from Lipniacki et al. and extended the model scope to incorporate IKK
activation. They complemented this computational work with additional wet-lab experimentation
(at the population-level of cells) that focused on constant stimulation with varying TNFα doses.
They found that both duration and dose of TNFα have little effect on the duration of the initial NF-κB
response and that NF-κB responds sensitively to a wide range of TNFα concentrations. Their in silico
experimentation predicted that these signal transduction properties were crucially dependent on the
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transient nature of IKK activity. Furthermore, they found the dynamics of IKK activity to be non-linear
in nature, which they conjecture could be the basis for ensuring robust TNFα-induced NF-κB responses
to offset limitations imposed through the diffusion of the ligand within the extracellular environment.
More recent work by Tay et al. [56] and Turner et al. [57], who incorporated a number of stochastic
processes within their computational models (see semi-stochastic models below), have shown that in
contrast to these population-level studies, the NF-κB response is heterogeneous at the single-cell level,
with fewer cells responding to lower doses of TNFα, due to the individual cell responses being
controlled by a stochastic threshold and, thus, yielding an all-or-nothing response [57].
Finally, the most recent deterministic model that we are aware of was developed by
Choudhary et al. [58], who predicted through in silico experimentation (and validated using siRNA
knockdown wet-lab experiments) that the canonical and non-canonical pathways are coupled through
the action of TNF associated factor 1 (TRAF1) and NF-κB-inducing kinase (NIK). They demonstrated
that TNF stimulation (of the canonical pathway) induces TRAF1 expression and that the newly
expressed TRAF1 binds to NIK (of the non-canonical pathway) with high avidity. They conjecture that
the TRAF1-NIK complex is a central component for cross-talk between the two NF-κB pathways,
as the TNF-induced delayed activation of the non-canonical pathway is dependent upon a feed-forward
mechanism activated by TRAF1 expression from the canonical pathway.
3.2. Semi-Stochastic (Hybrid) Differential Equation Models
Following from these initial ODE models, Lipniacki et al. have published two subsequent
increments of their model, by adding stochastic gene activation [59] and then stochastic receptor
activation by TNFα [60]; with the wider group also publishing two additional increments, by adding
granularity at the single-cell level [56] and incorporating positive feedback through TNFα
expression [61]. The first increment continued to use ODEs, but was reimplemented using the
MATLAB development tool, focused at the level of a single-cell instead of an averaged
population-level, and also introduced a stochastic switch to account for the activity of the genes relating
to A20 and IκBα. They did this by using four equations that account for the binding and dissociation
probabilities of NF-κB molecules to regulatory sites (in DNA) for A20 and IκBα promoters, the gene
transcription into mRNA and the resultant translation into A20 and/or IκBα proteins. This stochastic
gene activation facilitates the variability of protein concentrations within simulated cells, which is akin
to that seen in biology, e.g., the stochastic switch allows large variances in simulations due to
amplifying effects of mRNA synthesis and protein translation. We believe that this model by Lipniacki
et al. is the first to have successfully modelled the amplification cascade of the NF-κB signalling
pathway following gene activation.
The second increment by Lipniacki et al. used 15 differential equations to model the kinetics of
NF-κB signalling, but this time further increased the scope to incorporate the TNFα cell membrane
receptor and the enzyme IKK kinase (IKKK), which activates the IKK complex. The TNFα receptor
was incorporated into the amplification cascade described above (for the second generation Lipniacki
model) through its activation being stochastic. The authors performed manual parameter fitting for this
receptor activation, so that 90% of simulated cells are activated in the first 10 min of TNFα stimulation,
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and claim that predictions from their single-cell level simulation results agree qualitatively with
published IKK and NF-κB activity data of the population-level results from Cheong et al. [54].
However, unlike the population-level results of Cheong et al. [54] that suggest that TNFα dose has little
effect on the duration of the initial NF-κB response; their in silico experiments show that at a low
TNFα dose, only a fraction of cells are activated, but that in these activated cells, the amplification
mechanisms assure that the amplitude of the NF-κB nuclear translocation remains above a threshold.
Additional in silico experiments showed that low nuclear NF-κB concentration only reduces the
probability of gene activation, but does not reduce the gene expression of those responding. They
hypothesise that the two effects provide stochastic robustness in responding cells, allowing cells to
respond differently to the same stimuli, but causing their individual responses to be unequivocal. This
suggests that amplification-saturation dynamics are present within the model, due to the final cell
response at the level of NF-κB target genes being approximately equal, regardless of whether a single
receptor or 100 receptors were activated. It is currently unknown whether a single activated receptor is
sufficient to initiate a response of this magnitude in biological systems, so further wet-lab
experimentation is required in parallel to the computational work of this group.
The third increment was developed by Tay et al. [56], who augmented the mathematical model with
additional parameters so that it may be used with high-throughput single-cell resolution wet-lab
experimental data. The model contains 16 differential equations (some of which are stochastic in
nature) and 34 rate constants, 20 of which used fixed constants from published data, and the remaining
14 were manually fitted in order to calibrate simulations against single-cell traces. The most intriguing
finding from their wet-lab and in silico experiments, which was also independently discovered by
Turner et al. [57] during a similar time period, was that not all cells responded to TNFα and that the
fraction of activated cells decreased with decreasing TNFα dose, thus representing the discrete nature
of single-cell activation. They also found that early gene expression was not dependent on the intensity
of the inducing signal, but instead relied on the high amplitude of the NF-κB, which supported their
earlier hypothesis of robust NF-κB responses, even with relatively few cells responding. This model
has been used by Fallahi-Sichani et al. [62] as the intracellular basis of a hybrid model, by linking to
an existing high-level agent-based model of macrophage responses toMycobacterium tuberculosis (TB)
infection. They surmise that through manipulating NF-κB-mediated responses (particularly
macrophage activation and TNFα expression), you can improve the function of a TB granuloma to
contain the infection.
The fourth and final increment from the Lipniacki group was developed by Pekalski et al. [61],
who built on the model of Tay et al. [56] by adding the positive feedback associated with the expression
of TNFα. Their premise was that the first phase of the innate immune system detects pathogens through
membrane and cytoplasmic receptors and that this leads to activation of transcription factors (such as
NF-κB) and the production of proinflammatory cytokines, such as TNFα. The secretion of these
cytokines then leads to the second phase of the innate immune response in cells that have not yet
encountered the pathogen; with these cytokine-activated cells producing and secreting the same
cytokine and, thus, propagating the immune response through this positive feedback. They discovered
that the introduction of positive feedback changes system dynamics and may lead to long-lasting
NF-κB oscillations in wild-type cells and persistent NF-κB activity in A20-deficient cells.
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Additional work using hybrid models at the single-cell level has been performed by
Ashall et al. [63] and Paszek et al. [41]. Ashall et al. built on the findings of Nelson et al. [45]
discussed above. Instead of using the computational modelling in a predictive capacity, Ashall et al.
first commenced with wet-lab experimentation and then developed both deterministic and
semi-stochastic models to simulate the cellular behaviours. During the wet-lab experimental phase, they
exposed individual cells to pulses of TNFα at various time intervals between the pulses, to mimic the
pulsatile nature of inflammatory signals. They discovered that lower frequency stimulations generated
synchronous translocations of NF-κB across the nuclear membrane of equal magnitude with successive
pulses; whereas higher frequency stimulations generated synchronous translocations with reduced
magnitude for successive pulses, suggesting that this reflects a failure of the system to reset at higher
frequencies. A revised deterministic model, which modified the core network of IKK-NF-κB-IκBα and
the A20 inhibitor, which was able to replicate that, was the basis for Lipniacki et al. [47], which was
able to replicate the TNFα pulsatile stimulation data at the population-level, using a single parameter
set. As the deterministic model was unable to elucidate the heterogeneity of single-cell responses to
TNFα pulsatile stimulation, they augmented the model with stochastic processes for three negative
feedback mechanisms: transcription of IκBα, transcription of A20 and delayed transcription of IκB￿.
Like the deterministic model, this semi-stochastic model was able to simulate the wet-lab experimental
results and predict persistent oscillations after TNFα stimulation, suggesting that stochastic variation
due to the delayed transcription of IκB￿ may generate increased cell-to-cell heterogeneity.
Paszek et al. [41] subsequently built on this work of Ashall et al. by augmenting the transduction
pathway of the computational model with the kinase IKKK and calibrating the semi-stochastic
behaviour to the results of their new single-cell (wet-lab) experimentation into the kinetics of IκBα and
IκB￿ activation. Through the use of TNFα and IL-1β cytokines and the synthetic stimulus PMA
(phorbol ester differentiation factor phorbol 12-myristate 13-acetate), they discovered a transcriptional
delay between IκBα and IκB￿. Furthermore, they discovered a 45-min delay to transcription of both
IκBα and IκB￿ genes and that this delay did not substantially change the average timing or amplitude
of NF-κB oscillations at the population-level, but instead affected the single-cell timing of the
oscillations to maximise the heterogeneity. They therefore hypothesise that the network topology of the
NF-κB signalling system is stimulus-dependent and that the generation of cellular heterogeneity
maintains the functional responsiveness of individual cells, to promote tissue robustness.
Through these separate iterations, the models of Lipniacki et al., Tay et al., Ashall et al. and
Paszek et al. have now refined the initial Hoffmann model and indeed investigated new areas of the
signalling pathway from a computational perspective. We believe that the major achievements are:
consideration of the different nuclear and cytoplasmic volumes; introduction of stochasticity regarding
cell membrane receptor activation and gene activation, to facilitate modelling at the single-cell level;
the use of more accurate data as parameter values; and perhaps, most importantly, the rewriting of the
model using MATLAB, which is a more contemporary software development tool for
computer scientists.
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3.3. Agent-Based Models
Although quantitative mathematical models are well established tools for modelling complex
biological phenomena, they require an exhaustive set of precise parameters to be specified for each
variable. This is fine for small models that align to the dynamics of a few components; however, when
the scale is increased to capture a more realistic scope at the system-level [64], they begin to suffer from
limitations in accuracy, as data for use in analysing the effectiveness of differential equation models is
often unavailable from wet-lab immunological experiments [8]. As such, equation-based methods are
unable to fully model system dynamics at the individual component-level and, therefore, suffer
considerably from their inability to capture the natural variation inherent to all biological processes.
An alternative to these equation-based approaches is to model molecules or cells individually and
assign probabilities to each possible interaction or state change through rule-based techniques. The
individual component behaviours may then be aggregated up to system-level dynamics, which are then
extrapolated in order to make predictions of the system-level behaviours in real biology [65,66].
Interestingly, it would appear that a large amount of data generated experimentally in biology
actually accumulates in an object-oriented manner. The reductionist approach, which endeavours to
look at systems using the smallest indivisible unit, is analogous to looking for “objects” within nature.
Object-oriented approaches to modelling, therefore, provide a useful formalism for constructing
computational models by designing systems from a bottom-up perspective and organising information
around individual objects [67]. Agent-based modelling and simulation (ABMS) builds on the
object-oriented paradigm, with the key enhancement being that an agent is active rather than passive
and that ABMS has multiple threads of control. Macal and North [68] nicely describe this by stating
that the “fundamental feature of an agent is the capacity of the component to make independent
decisions”. The agent-based approach therefore allows systems to be modelled at the resolution of
individual components and allows us to model at the level of the individual molecule the
spatio-temporal aspects of system dynamics, such as translocation of components between cell
compartments, and also simulate their individual position in three-dimensional space.
Following from the early successes with equation-based computational models, Pogson et al. [69]
took the modelling of the pathway’s stochastic behaviour one step further, by developing an
agent-based model of the NF-κB signalling module. This computational model was developed in
MATLAB and utilised the concept of communicating X-machines [70] to represent the individual
agents and their associated interactions. They chose to break away from the pattern of using differential
equations, which relied on the assumption that a cell is homogenous with respect to its chemical
constituents. We agree with this stance and believe that such an assumption will not be valid, due to the
cells’ internal compartmentation and the non-uniform distribution of key molecules [9]. An important
aspect of communicating X-machines is that each agent has memory, which in this instance, holds the
current physical location and current state and may also contain a set of randomised parameter values
(from a given distribution of suitable parameter values), to further instil stochasticity into the model.
Pogson et al. used a set of autonomous agents within their model that correspond to: NF-κB dimer,
IκBα, cell membrane receptor, nuclear importing receptor and nuclear import-export receptor.
Furthermore, they used a greater level of detail regarding translocation of molecules across the nuclear
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membrane and added a three-dimensional spatial dimension using continuous space to the model,
which the differential equations used by Hoffmann et al. and Lipniacki et al. are unable to represent,
and to a higher degree of granularity than the partial differential equations (PDEs) used by Terry and
Chaplain [71] and Ohshima et al. [72] could represent.
The mathematical underpinning of this agent-based model is based on generalised biochemical
reaction kinetics of two substrate molecules interacting and forming a product molecule.
Graphical visualisation of the reactions allows us to view the dynamics of the system over time,
for example the increase of product molecules (e.g., NF-κB-IκBα complex) and the associated decrease
in substrate molecules (e.g., free NF-κB and free IκBα) during an inhibitory reaction. As the relevant
components are located within three-dimensional space (X, Y, Z co-ordinates), the authors built in
an interaction radius to each molecule to ensure that a chemical reaction only occurs when the requisite
substrate molecules come within a certain distance of each other. They abstracted the interaction radius
of molecules to be a sphere; clearly, a number of biochemical components have orientations, through,
for example, polarity and non-symmetrical quarternary structure; however, we believe this to be
an appropriate approximation to biology for the purposes of the model.
Simulations (using the model) were run as a discrete-event system, with each iteration of the
simulation run representing a defined period within time, i.e., constant time step. The authors validated
the model against single-cell analysis wet-lab data of Carlotti et al. [34,48] and Yang et al. [73], who
used fluorescent tagging and confocal microscopy to observe IκBα degradation and NF-κB shuttling
dynamics. Successive time-step iterations were therefore able to relate to the temporal observations of
single-cell analysis experiments, and the model therefore reflects the discrete stochastic nature of
sub-cellular events.
Pogson et al. later updated the original model and performed in silico experimentation to predict
internal cell structural components in regulating the NF-κB signalling pathway [50]. This revised
model made the IKK complex explicit and introduced the transcription and translation of the three IκB
isoforms (IκBα, IκBβ and IκB￿), as per the model of Hoffmann et al. IκBβ and IκB￿ were included in
the model to introduce more accurate stochasticity in the inhibition of NF-κB and reduce the overall
probability for NF-κB-IκBα complex formation. As with the 2006 model, this augmented model was
also validated against single-cell analysis data [34,73] and sensitivity analysis demonstrated a narrow
range of acceptance for IKK levels, robustness to NF-κB and IκBα levels and importantly greater
sensitivity to IκBα than for NF-κB. Furthermore, simulation results yielded a negative feedback loop
consistent with the models of Hoffmann et al. and Lipniacki et al.
Through in silico experimentation, the authors demonstrated an increase in NF-κB nuclear
translocation at a 1:1 NF-κB:IκB ratio (which is to be expected) and focused on the cytoskeletal
structural component of the cell to which IκB can bind. Simulations of cytoskeleton-IκB interactions
yielded a maximal NF-κB-IκB complex formation at a 1:3 ratio NF-κB:IκBα. Without actin, the
maximal was reached at a 1:1 concentration ratio. The authors hypothesise that this key role for
cytoskeleton-associated interactions sustains optimal pathway regulation by adjusting the NF-κB-IκB
complex formation at the steady-state and controlling negative feedback following activation of the
signalling pathway. Subsequent wet-lab experiments (performed by the authors) demonstrated a ratio of
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actin-bound to free IκBα of 2:1 in unstimulated cells, indicating that two-thirds of IκBα may be bound
to the cytoskeleton at steady-state.
3.4. Peer-Validation of These Computational Models
Adverse effects of over-transfection were initially observed by Carlotti et al. [48] and
Yang et al. [73], who compared the control of exogenous, tagged intermediates with results from
immunocytochemical experiments to identify transfection limits in regards to cell-to-cell variations and
regulation of NF-κB. This risk of over-transfection was initially leveraged by Barken et al. [74] as
a limitation of the work by Nelson et al. [45] based on single-cell readings. However, this debate has
recently been resolved and the initial observations by Nelson et al. confirmed, through the work of
Tay et al. [56] and Sung et al. [75] on stable cell lines, as well as the work of Sung et al. [76] and
Zambrano et al. [77] on p65 EGFP knock-in transgenic animals.
We also believe that continued refinement and augmentation of these existing models will in all
likelihood yield a computational model that will be able to accurately predict observed biological
phenomena across both single-cell and averaged population levels, and we suggest that the recent work
of Tay et al. [56] and Turner et al. [57] has made an important contribution towards this end. They have
both shown through single-cell analysis with TNFα and associated stochastic modelling that NF-κB
activation is heterogeneous and is a digital process, with fewer cells responding at low doses.
Additionally, Turner et al. also found that cells display analogue processing to modulate system
dynamics, by controlling NF-κB peak intensity, response time and the number of oscillations.
Hayot and Jayaprakash [78] incorporated the Gillespie algorithm [79] into the model for the study of
cell-to-cell variability, along with the replacement of the quadratic (second order) nuclear
NF-κB-induced synthesis of IκBα with a linear (first order) term, following the reasoning of
Nelson et al. [45] and Lipniacki et al. [47]. This augmented model found the fluctuations of NF-κB to
agree with Hoffmann et al. [35] and predicted that these fluctuations are small when transcription is
strong (as used within the Hoffmann model), whether transcription is linear or quadratic, but that
intrinsic fluctuations can be strong and, indeed, as significant as any extrinsic noise if the rate of
promoter binding is low.
Other groups have used models to validate their in-house wet-lab experimental data, including:
Ihekwaba et al. [80,81], who performed a parameter refit for IκBβ and IκB￿, discovered, through using
sensitivity analysis, that the model is particularly sensitive to parameters relating to IKK and IκBα and
that overexpression of IκBα in transfected cells would yield a minimal perturbation to the system;
Mathes et al. [82], who added IκBα degradation functionality for both IKK-mediated degradation of
NF-κB-bound IκBα and IKK-independent degradation of free IκBα; and Wang et al. [83], who adapted
the model to simulate single-cell data using short and strong pulses of TNFα and found that weak
pulses provide a rich variety of non-linear temporal signalling dynamics, which may account for the
diversity of expression patterns for the multitude of target genes in the signalling pathway.
Similarly, Yue et al. [84], who performed a sensitivity analysis, focusing in particular on local
sensitivities through bifurcation/pairwise studies; Joo et al. [85], who performed global sensitivity
analyses using orthogonal array sampling, Latin hypercube and k-means clustering and confirmed that
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the IKK-NF-κB-IκBα-A20 interaction network is the key portion of the wider pathway (as suggested
by Lipniacki et al. [47,59]), as these components have critical kinetic rate variables for IKK activation;
and Ashall et al. [63], who performed wet-lab experimentation by treating cells with short pulses of
TNFα to mimic pulsatile inflammatory signals and, through in silico experimentation on a model,
augmented with various inhibitors, predicted that negative feedback loops regulate both the resetting of
the system and cellular heterogeneity, through limiting the reactivation of IKK.
3.5. Minimal Models
The models discussed above have represented mathematical and computational abstractions of the
major components of the NF-κB signalling pathway. It has recently been argued by a number of
different groups, however, that the complex nature of these models makes them computationally
expensive to run and also requires complicated analysis techniques in order to make inferences from
simulation results. As such, these groups have developed what have been termed minimal models,
which are able to replicate the majority of the phenomenological behaviours of the more complex
computational models, but which use the minimum number of equations possible. We therefore discuss
within this section the four minimal models from Krishna et al., Yde et al., Longo et al. and
Zambrano et al., along with the model reduction algorithm developed by West et al.
The first minimal model after that of Carlotti et al. [34] was developed by Krishna et al. [86]
and focused on a small core network of the pathway that drove oscillatory behaviour. Through reducing
the model of Hoffmann et al. down to a core feedback loop of three coupled ODEs, they were able to
ascertain the minimal model required to generate oscillations. This simplified model was validated
against the work of Hoffmann et al. and Nelson et al. and was able to simulate: the sustained
oscillations obtained with only the IκBα isoform of IκB; the damped oscillations in wild-type cells that
included the other forms of IκB (e.g., IκBβ and IκB￿); the spikiness of nuclear NF-κB and the
asymmetry of cytoplasmic IκB oscillations; and the phase difference between NF-κB and IκB. Their
key finding was that saturation degradation of cytoplasmic IκB in the presence of IKK was crucial for
oscillatory behaviour, because it sets an upper limit within the system for the degradation rate and, thus,
allows IκB to accumulate and remain in the system for longer than with linear degradation rates. They
conjecture that this effectively introduces a time delay into the negative feedback loop, which is known
to generate oscillations.
The authors were subsequently involved in the development of another minimal model
(Yde et al. [87]). Here, they modelled the amplification of the immune response, following
cytokine-mediated activation of the NF-κB pathway, and the positive feedback that occurs through
upregulation of cytokine expression (as previously modelled by Werner et al. [88]). The ODE model
was developed at the tissue-level (cell population level), with the detailed network dynamics of the
NF-κB signalling pathway within individual cells abstracted away. In fact, they discovered that
tissue-level immune responses were able to emerge within the minimal model through using only three
(high-level) variables, relating to: NF-κB, a generic regulator and a generic inhibitor. The model
predicts that cytokines produced by the stimulated cell(s) at the site of infection diffuse away from this
primary infection site and trigger the transient response of the NF-κB pathway for the production of
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cytokines in neighbouring cells. They conjecture that this generates a propagating wave of NF-κB
induction and cytokine production throughout the infected tissue.
Like the minimal model of Krishna et al. [86] above, Longo et al. [89] also used the Hoffmann
model as the basis for developing a minimal model of negative feedback within the NF-κB signalling
pathway. This new model used a single delayed compound reaction to replace the cascading reactions
that had been utilised previously [35]. They used this to investigate the underlying mechanisms
involved with oscillations and the dampening of oscillations that emerged through the two negative
feedback loops of the inhibitors IκBα and IκB￿. Through investigating the oscillatory responses using
the single negative feedback associated with IκBα, they discovered that both the frequency and decay
rate of the oscillations are highly dependent on the internal parameters of the core network of the
signalling module, but are not sensitive to extracellular stimuli levels. They suggest that the oscillatory
frequency within the system can therefore not be encoding information about the stimulus and
conjecture that stimulus-specific gene expression is therefore unlikely to be determined by the
stimulus-specific frequencies of NF-κB oscillations; and therefore, may involve amplitude modulation
over time. Furthermore, upon introduction of IκB￿ into the model, the authors were able to reproduce
the findings of their previous work [40], where the oscillations caused by persistent stimulation were
now significantly dampened. They suggest that the second negative feedback mechanism (IκB￿) may
have evolved to produce dampening of the oscillatory behaviour of the first feedback
mechanism (IκBα).
An alternative approach has been taken by Zambrano et al. [90], however, whereby the ODE-based
model is developed according to the different layers of processes within the cell environment.
They have used a three-layer approach, with the first layer representing the transcription and translation
of new IκBα molecules; the second layer representing the NF-κB signalling module and its negative
feedback by IκBα; and the third layer representing the commencement and propagation of signal
following the recognition of extracellular stimuli at the cell membrane, down to the activation of IKK.
Their model was able to replicate both the heterogeneity of the system seen in the models of
Tay et al. [56], Paszek et al. [41] and Sung et al. [76], along with the spiky oscillations shown by
Krishna et al. [86]. As such, the authors believe that the community should make more use of minimal
models as a basis for investigating the underlying mechanisms of the NF-κB signalling pathway
and that the reliance on complicated computational models should be minimised, because they incur the
risk of being overfitted to the specific wet-lab experiments from individual groups and, thus, may not be
used by the wider community, who use different in vitro models.
Finally, along with the explicit development of minimal models by individual groups, recent work by
West et al. [91] has focused on the development of algorithmic methods to enable a principled approach
for reducing existing differential equation-based models into new minimal models. Their algorithmic
approach is based on quasi-steady-state approximations and produces a set of ranked variables
according to how quickly they approach their momentary steady-state. Once ranked, the developer may
then eliminate variables at each step within the related equation-based model, whilst preserving the
system-wide dynamics. The authors tested their reduction algorithm on the two feedback (IκBα and
A20) models of Ashall et al. [63] and the original ODE model by Krishna et al. [86] (upon which the
Computation 2014, 2 148
minimal model was extracted) and report that the system dynamics that emerge from the reduced
models compares favourably with the original, more complex models.
4. Discussion and Perspectives
The complexity of the innate immune system, and in particular the inflammatory process, has been
difficult to fully investigate using reductionist and linear approaches alone, since it is characterised by
non-linear kinetics, as well as numerous feedback loops. Several signalling pathways relating to the
combating of various pathogenic infections converge on NF-κB activation, resulting in a highly
complex regulatory system for the innate immune response. Since the discovery of NF-κB in
1986 [12], there have been over 49,000 journal articles published (figures from PubMed on March 5,
2014). We believe the NF-κB signalling pathway to be a good candidate for research that follows
a systems biology approach to further our understanding. Computational modelling to date has
successfully complemented traditional wet-lab techniques to generate hypotheses on the mechanistic
behaviour of the various components of the signalling pathway (see Table 1 for the major
computational modelling advancements). As such, these in silico-derived predictions are helping to
further our understanding of in vitro system dynamics, in particular how signals received by the IKK
complex are propagated down the signal transduction pathway through activation of the NF-κB
signalling module. This computational experimentation has given rise to the belief that IKK regulatory
mechanisms may represent sensitive clinical targets in diseases with aberrant innate immune system
activity. There appears to be an opportunity to expand the scope of these current models, however, to
also encompass upstream events prior to IKK activation, thus incorporating a greater degree of
granularity for cell membrane receptor complexes, and to expand the scope to additional gene
transcription products. This would allow us to simulate the induction of the pathway through various
extracellular signals and to capture activation of transcription for target genes (other than IκB isoforms)
that are relevant to the inflammatory response, for example various cytokines.
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Table 1. The top 20 computational models (in chronological order) that we believe have facilitated increased understanding of the
NF-κB signalling pathway. Along with the year of journal article publication, we have also documented: the modelling paradigm used
(deterministic, semi-stochastic, or agent-based), the specific extracellular stimulus (if any), the specific cell type (if any), the hierarchical
level of the model (single-cell or population), the pathway components that were explicitly modelled, and the key advances of the model.
Year Authors Modelling Paradigm Stimuli Cell Type Level Pathway Components Key Advances
2000 Carlotti et al. [34] Deterministic IL-1 Monkey Smooth Muscle Single-Cell NF-κB, IκBα
First known model of NF-κB and IκBα
dissociation and translocation dynamics.
2002 Hoffmann et al. [35] Deterministic TNFα Mouse Fibroblast Population
IKK, NF-κB, IκBα,
IκBβ, IκB￿
First model of TNFα induced activation of the
signalling pathway.
2004 Lipniacki et al. [47] Deterministic - - Population IKK, NF-κB, IκBα, A20
Incorporated 2-feedback loop (IκBα and A20)
to Hoffmann model and parameter refit.
2004 Nelson et al. [45] Deterministic TNFα Human HeLa and SK-N-AS Single-Cell IKK, NF-κB, IκBα
First model to show NF-κB oscillations
at single-cell level. Augmented Hoffmann
model using single-cell data for calibration
and validation.




First known agent-based model of
signalling pathway.
2006 Lipniacki et al. [59] Semi-Stochastic TNFα - Single-Cell
IKK, NF-κB, IκBα,
A20, mRNA, genes
Stochastic transcription to generate
cellular heterogeneity.
2006 Cheong et al. [54] Deterministic TNFα Mouse Embryonic Fibroblast Population IKK, NF-κB, IκBα
Incorporated temporal profiles of
IKK activation.
2006 Kearns et al. [40] Deterministic TNFα Mouse Embryonic Fibroblast Population
IKK, NF-κB, IκBα,
IκBβ, IκB￿
Reimplementation of Hoffmann model in
Matlab. Showed that IκB￿ provides negative
feedback control of NF-κB oscillations.
2007 Basak et al. [42] Deterministic LTβR Mouse Embryonic Fibroblast Population
IKK1, IKK2, NF-κB,
IκBδ
Incorporated fourth IκB inhibtor (nfkb2 p100,
or IκBδ). Models cross-talk of canonical
NF-κB/RelA activity in response to
non-canonical IKK1-induction.
2007 O’Dea et al. [38] Deterministic TNFα Mouse Embryonic Fibroblast Population
IKK, NF-κB, IκBα,
IκBβ, IκB￿
Distinguished between NF-κB bound and free
IκB pools. Investigated steady-state regulation
of NF-κB signalling module.




Incorporated stochastic switches for cell
membrane receptor activation by TNFα ligand,
and transcription of IκBα and A20 genes.
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Table 1. Cont.
Year Authors Modelling Paradigm Stimuli Cell Type Level Pathway Components Key Advances





Updated earlier ABM with transcription and
translation of IκBα to provide negative
feedback. Also incorporated sequestration of
excess IκBα to cytoskeleton.




Mouse Embryonic Fibroblast Population
IKK, NF-κB, IκBα,
IκBβ, IκBδ, IκB￿
Modelled the 4 distinct IκB variants and
utilised TNFα, IL-1 and LPS stimulation to
determine signal specificity for the negative
feedback loops.






Incorporated delayed stochastic transcription
of IκB￿, and stochastic transcription of IκBα
and A20.




Updated to reflect the heterogeneous, digital
response of single cells, and the analogue
dynamics of peak NF-κB intensity, response
time and oscillation number, to modulate the
overall population response.




Aggregated large-scale single-cell dynamics to
show that cellular heterogeneity (for timings
of NF-κB oscillations) is important for
population-level robustness.




Updated Ashall model to incorporate








Merged their previous ABM of granuloma
formation (did not model NF-κB) with the
ODE model of Tay, to develop a multi-scale
hybrid model.




Integrated canonical and non-canonical
pathways, using TRAF1-NIK as
a feed-forward complex.




Built on Tay model to integrate negative and
positive feedback loops due to IκBα and A20,
and TNFα respectively.
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NF-κB has wide-ranging effects controlled by a complex regulatory network of inhibitors and
co-activators. Understanding the mechanisms that control NF-κB activation/cellular signalling is
important for exploiting therapeutic approaches to treat human disorders due to its dysregulation.
Specific targets for therapeutic agents could be the transcription factor itself or any of the associated
components within the pathway, including protein kinases and the IκB inhibitors themselves.
Gilmore and Herscovitch [92] reviewed the known inhibitors of NF-κB, which may provide a basis for
future research regarding computational modelling and subsequent pharmacological intervention.
In conclusion, we believe that computational models tightly coupled to wet-lab experimental
analysis will be indispensable to furthering our understanding of the NF-κB signalling pathway.
Furthermore, with the advances in software modelling technologies and computational power over the
past decade, we believe that the timing is right for the development of agent-based models of the
NF-κB signalling pathway on a scale that has not been seen before. New technologies, such as Java
Mason [93], which allows large agent-based simulations to be developed, which can be manipulated
in real-time during simulations, or FLAME (Flexible Large-Scale Agent-Based Modelling
Environment) [94,95], which has recently been used to model the European economy, and the GPU
version of FLAME [96], allow massively parallel agent-based simulations to be run. Along with these
advances in technology, recent developments in cell biology have also advanced our corresponding
understanding the pathway. We believe a number of key questions may be answered through the
development of large-scale computational models of NF-κB. From a cell biology perspective, these are:
(i) what can in silico experimentation tell us about the relative roles of the intermediate components
within the signal transduction events; (ii) what can in silico experimentation tell us about the various
receptors, co-receptors and adaptor proteins and their role(s) in signal transduction events; (iii) what can
in silico experimentation tell us about the dysregulation that can occur in diseased states, and how can
we perturb the system back to a healthy state; and (iv) what can in silico experimentation tell us about
the cross-talk that occurs when various extracellular signals converge on the NF-κB signalling module.
There are also a number of key questions from a modelling perspective: (i) does the abstraction level
affect the accuracy of simulation-driven predictions; (ii) does the resolution level (e.g., number of
agents) affect the accuracy of simulation-driven predictions; (iii) does the simulation platform (different
technology, e.g., equation-based versus agent-based) affect the accuracy of predictions; (iv) what are
the relative merits of averaged population data versus single-cell data for the calibration and validation
of computational models; (v) what are the advantages and limitations of using massively parallel
computing architectures, for reproducing the large-scale variation (as seen in biological systems) into
computational simulations; and (vi) what can inference techniques (e.g., Bayesian inference) tell us
about the relative merits of the existing computational models and their associated parameter value sets?
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